dr. covey on recent and future changes to the nccn guidelines for hcc
Published 8 years ago • 355 plays • Length 1:56Download video MP4
Download video MP3
Similar videos
-
4:18
the future of hcc management
-
1:53
dr. do on the assessment of tumor response in liver cancer
-
1:44
evolving nccn guidelines for mpns
-
1:17
dr. ruben mesa on new nccn guidelines for mpns
-
3:15
advances in systemic therapy for hcc
-
7:13
immunotherapy in hcc
-
4:58
case 1: genomic testing & nccn guidelines for metastatic crc
-
3:46:29
nccn virtual oncology policy summit: the impact of technology on cancer care in 2021
-
6:40
systemic therapy for advanced hcc
-
4:55
the complexities of hepatocellular carcinoma
-
43:07
nccn keynote: 20 years of improving the quality, effectiveness, and efficiency of cancer care
-
1:08
what are the nccn guidelines?
-
10:17
resectability of hcc
-
1:13
steven j. cohen, md, discusses vemurafenib and the nccn guidelines for mcrc patients
-
1:28
dr. yao on the milan criteria in liver cancer
-
1:49
kalinsky discusses results from rxponder breast cancer clinical trial
-
1:09:36
nccn patient webinar: inflammatory breast cancer
-
1:16
dr. madoff on selecting patients with hcc appropriate for minimally invasive surgery
-
1:08
ask unmc: oncology specialist for gyn cancers